Compare MDB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDB | RMD |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0B | 28.4B |
| IPO Year | 2017 | N/A |
| Metric | MDB | RMD |
|---|---|---|
| Price | $331.46 | $187.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 10 |
| Target Price | ★ $368.67 | $292.56 |
| AVG Volume (30 Days) | ★ 2.4M | 1.4M |
| Earning Date | 06-03-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | ★ 49.13 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.68 | $10.60 |
| Revenue Next Year | $17.10 | $7.41 |
| P/E Ratio | $6,657.00 | ★ $25.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $198.47 | $180.27 |
| 52 Week High | $444.72 | $293.81 |
| Indicator | MDB | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 38.14 |
| Support Level | $309.71 | $180.27 |
| Resistance Level | $341.95 | $260.21 |
| Average True Range (ATR) | 25.56 | 4.80 |
| MACD | -5.36 | 0.21 |
| Stochastic Oscillator | 17.60 | 38.58 |
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.